Indoco Remedies Ltd (INDOCO)

NSE · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

₹208.30

As of 30 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close ₹208.30 on 30 Oct 2026. The share price traded between ₹162.19 and ₹288.00 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close ₹208.30

Low ₹162.19High ₹288.00

Market cap₹1,875 crorelast close × shares
P/E341.5on reported profit, last four quarters
Profit, last 12 months₹5.49 crto shareholders
Profit incl. minorities₹3.00 crlast 12 months
Return on equity−9.4%year to Mar 2026
EBITDA margin8%year to Mar 2026
Debt to equity1.16year to Mar 2026
Net margin−5.4%year to Mar 2026
Dividend yield0.09%last 12 months

Price trend

Revenue and profit

RevenueNet profit₹ crore
-50005001,0001,5002,000
YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue1,5411,6691,8171,6651,845
Net profit15514297-78-99
EBITDA margin21%17%13%6%8%
Borrowings2573336729941,090

₹ crore. Over three years, compounded: revenue grew 3.4% a year.

Recent filings

Questions about Indoco Remedies Ltd

What is Indoco Remedies Ltd's market value?

Indoco Remedies Ltd's market value is ₹1,875 crore as of 30 Oct 2026 close: the last close times the shares in issue. Its P/E is 341.5, the last close over earnings per share for the last four reported quarters.

Who are Indoco Remedies Ltd's largest named shareholders?

In the shareholding pattern for the quarter ended 30 Sep 2026, the largest named holders above 1% were: SPA HOLDINGS PVT LTD (promoter group) 19.86%; SHANTERI INVESTMENT PVT LTD (promoter group) 17.18%; KARE FAMILY PRIVATE TRUST (promoter group) 14.19%. Percentages are of all shares.

Go further with INDOCO

Free to start: test a trading idea on INDOCO's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceuticals), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

P/E 341.5 is the close over earnings per share, the profit that belongs to the company's shareholders (market cap divided by P/E: 5 crore for the last 12 months, shown above). The net profit including the share owned by minority shareholders of subsidiaries is 3 crore; market cap divided by that gives 624.9. The last 12 months are the four latest reported quarters, so their profit can differ from the newest year's in the table below.